ERAP1 is over-expressed in a number of tumor cell lines, and ERAP1-deficient tumor cells are more susceptible to NK cell mediated lysis, the latter possibly due to altered interactions of MHC class I molecules with the NK cell inhibitory receptors (e.g. Ly49C) [15], [16], [17]. The gene discussed is ERAP1; the disease is neoplasm.